Antonio Fernández-Nebro

Antonio Fernández-Nebro

UNVERIFIED PROFILE

Are you Antonio Fernández-Nebro?   Register this Author

Register author
Antonio Fernández-Nebro

Antonio Fernández-Nebro

Publications by authors named "Antonio Fernández-Nebro"

Are you Antonio Fernández-Nebro?   Register this Author

66Publications

2794Reads

48Profile Views

Efficacy and safety of Rituximab in vasculitic neuropathy: a systematic review of the literature.

Reumatol Clin 2019 May - Jun;15(3):173-178. Epub 2019 Jan 25.

Servicio de Reumatología, Instituto de Investigación Biomédica de Málaga (IBIMA), Hospital Regional Universitario de Málaga, Universidad de Málaga, Málaga, España.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S1699258X183023
Publisher Site
http://dx.doi.org/10.1016/j.reuma.2018.10.007DOI Listing
January 2020

Analysis of Clinical-Analytical Characteristics in Patients with Rheumatoid Arthritis and Interstitial Lung Disease: Case-Control Study.

Reumatol Clin 2019 Aug 29. Epub 2019 Aug 29.

UGC de Reumatología, Hospital Regional Universitario de Málaga, Instituto de Investigación Biomédica de Málaga (IBIMA), Málaga, España.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.reuma.2019.06.001DOI Listing
August 2019

Analysis of effectiveness, safety and optimization of tocilizumab in a cohort of patients with rheumatoid arthritis in clinical practice.

Reumatol Clin 2019 Jan - Feb;15(1):21-26. Epub 2017 Jul 1.

Unidad de Gestión Clínica de Reumatología, Instituto de investigación Biomédica de Málaga (IBIMA), Hospital Regional Universitario de Málaga, Universidad de Málaga, Málaga, España. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S1699258X173013
Publisher Site
http://dx.doi.org/10.1016/j.reuma.2017.05.012DOI Listing
June 2019

Bacteremia in Systemic Lupus Erythematosus in Patients from a Spanish Registry: Risk Factors, Clinical and Microbiological Characteristics, and Outcomes.

J Rheumatol 2019 Apr 15. Epub 2019 Apr 15.

From the Department of Rheumatology, Doctor Negrín University Hospital of Gran Canaria, Las Palmas; Department of Rheumatology, Gregorio Marañón University Hospital, Madrid; Department of Preventive Medicine, University Hospital Complex, and Department of Rheumatology, Biomedical Research Institute of Vigo, Vigo; Department of Rheumatology, Doce de Octubre University Hospital, Madrid; Department of Rheumatology, Donostia Hospital, Guipuzcoa; Infectious Diseases Department, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofia University Hospital, University of Cordoba, Córdoba; Department of Rheumatology, General University Hospital of Alicante, Miguel Hernandez University, Alicante; Department of Rheumatology, La Princesa University Hospital, Madrid; Department of Rheumatology, Bellvitge Hospital, Barcelona; Department of Rheumatology, Germans Trías i Pujol University Hospital, Badalona; Department of Rheumatology, University Hospital of A Coruña, A Coruña; Department of Rheumatology, University Hospital Complex of Ourense, Ourense; Department of Rheumatology, Puerta del Hierro-Majadahonda University Hospital, Majadahonda; Department of Rheumatology, Marqués de Valdecilla University Hospital, Cantabria University, Santander; Department of Rheumatology, University Hospital Araba, Victoria; Department of Rheumatology, Virgen Macarena Hospital, Seville; Department of Rheumatology, San Cecilio Hospital, Granada; Department of Rheumatology, Monforte Hospital, Lugo; Department of Rheumatology, Tenerife Clinic Hospital, Tenerife; Department of Rheumatology, Carlos Haya Hospital, Málaga; Department of Rheumatology, Son Llatzer Hospital, Palma de Mallorca; Department of Rheumatology, Doctor Peset Hospital, Valencia; University of Las Palmas, Gran Canaria, Las Palmas, Spain. This work was supported by the Spanish Foundation of Rheumatology. J.M. Pego-Reigosa is supported by grant 316265 (BIOCAPS) from the European Union 7th Framework Programme (FP7/ REGPOT-2012-2013.1) and FIS/ISCIII-Fondo Europeo de Desarrollo regional (grant number PI11/02857). I. Rúa-Figueroa, MD, Department of Rheumatology, Doctor Negrín University Hospital of Gran Canaria; F.J. López-Longo, MD, PhD, Department of Rheumatology, Gregorio Marañón University Hospital; V. Del Campo, MD, PhD, Department of Preventive Medicine, University Hospital Complex, Biomedical Research Institute of Vigo; M. Galindo-Izquierdo, MD, PhD, Department of Rheumatology, Doce de Octubre University Hospital; E. Uriarte, MD, Department of Rheumatology, Donostia Hospital, J. Torre-Cisneros, MD, PhD, Infectious Diseases Department, IMIBIC, Reina Sofia University Hospital, University of Córdoba; P. Vela, MD, PhD, Department of Rheumatology, General University Hospital of Alicante, Miguel Hernandez University Alicante; E. Tomero, MD, Department of Rheumatology, La Princesa University Hospital; J. Narváez, MD, PhD, Department of Rheumatology, Bellvitge Hospital; A. Olivé, MD, PhD, Department of Rheumatology, Germans Trías i Pujol University Hospital; M. Freire, MD, Department of Rheumatology, University Hospital of A Coruña; E. Salgado, MD, PhD, Department of Rheumatology, University Hospital Complex of Ourense; J.L. Andreu, MD, PhD, Department of Rheumatology, Puerta del Hierro-Majadahonda University Hospital; V. Martínez-Taboada, MD, PhD, Department of Rheumatology, Marqués de Valdecilla University Hospital, Cantabria University; J. Calvo-Alén, MD, PhD, Department of Rheumatology, University Hospital Araba; B. Hernández-Cruz, MD, PhD, Department of Rheumatology, Virgen Macarena Hospital; E. Raya, MD, Department of Rheumatology, San Cecilio Hospital; V. Quevedo, MD, Department of Rheumatology, Monforte Hospital; L. Expósito Pérez, PhD, Department of Rheumatology, Tenerife Clinic Hospital; A. Fernández-Nebro, MD, PhD, Department of Rheumatology, Carlos Haya Hospital; M. Ibañez, MD, Department of Rheumatology, Son Llatzer Hospital; È. Pascual-Valls, MD, Department of Rheumatology, Doctor Peset Hospital; D. Rúa-Figueroa, MD, University of Las Palmas; A. Naranjo, MD, PhD, Department of Rheumatology, Doctor Negrín University Hospital of Gran Canaria; J.M. Pego-Reigosa, Department of Rheumatology, University Hospital Complex, Biomedical Research Institute of Vigo. Address correspondence to Dr. I. Rua-Figueroa, Rheumatology Department, Hospital Universitario de Gran Canaria Doctor Negrín, Bco. De La Ballena s/n, 35011-Las Palmas de G. Canaria, Spain. E-mail: Accepted for publication March 26, 2019.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.180882DOI Listing
April 2019

Genetic variation at the glycosaminoglycan metabolism pathway contributes to the risk of psoriatic arthritis but not psoriasis.

Ann Rheum Dis 2019 03 14;78(3). Epub 2018 Dec 14.

Rheumatology Research Group, Vall d'Hebron Research Institute, Barcelona, Spain

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/annrheumdis-2018-214158DOI Listing
March 2019

Biological Treatment Patterns in Patients with Inflammatory Joint Diseases. Retrospective Study with 4 Years Follow-up.

Reumatol Clin 2019 Jan 28. Epub 2019 Jan 28.

Departamento de Reumatología, Instituto de Investigación Biomédica (IBIMA), Hospital Regional Universitario de Málaga, Universidad de Málaga, Málaga, España.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.reuma.2018.11.007DOI Listing
January 2019

Expert recommendations on the psychological needs of patients with rheumatoid arthritis.

Rheumatol Int 2018 12 28;38(12):2167-2182. Epub 2018 May 28.

Rheumatology Service, 12 de Octubre University Hospital, Av. Cordoba, s/n, 28041, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00296-018-4057-6DOI Listing
December 2018

Adherence of rheumatoid arthritis patients to biologic disease-modifying antirheumatic drugs: a cross-sectional study.

Rheumatol Int 2017 Oct 19;37(10):1709-1718. Epub 2017 Jun 19.

UGC de Reumatología, Instituto de Investigación Biomédica de Málaga (IBIMA), Hospital Regional Universitario de Málaga, Universidad de Málaga, Pabellón C: "Hospital Civil", Plaza del Hospital Civil s/n, 29009, Málaga, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00296-017-3758-6DOI Listing
October 2017

Cardiovascular disease in immune-mediated inflammatory diseases: A cross-sectional analysis of 6 cohorts.

Medicine (Baltimore) 2017 Jun;96(26):e7308

aRheumatology Department and Instituto de Investigación Sanitaria San Carlos (IdISSC), Hospital Clínico San Carlos, Madrid bRheumatology Research Group, Vall d'Hebron Hospital Research Institute cDepartment of Medicine, University of Barcelona, Barcelona dGastroenterology Department, Hospital Universitario de la Princesa, Instituto de Investigación Sanitaria Princesa (IIS-IP), Madrid eCentro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD) fGastroenterology and Hepatology Department, Hospital Universitari Germans Trias i Pujol, Badalona gUGC Reumatología, Instituto de Investigación Biomédica de Málaga, Hospital Regional Universitario de Málaga, Universidad de Málaga, Málaga hRheumatology Department, Hospital Clinic and IDIBAPS iDermatology Department, Hospital Universitari Germans Trias i Pujol, Badalona jUniversidad Autónoma de Barcelona, Barcelona kRheumatology Department, Hospital General Universitario de Guadalajara, Guadalajara lHospital Universitario Reina Sofía, Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Universidad de Córdoba, Córdoba mHospital Clínic de Barcelona and IDIBAPS, Barcelona nDermatology Department oRheumatology Department, Complejo Hospitalario Universitario A Coruña, INIBIC, A Coruña pRheumatology Department, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat qRheumatology Department, Hospital Universitario Doce de Octubre, Madrid, Spain.

View Article

Download full-text PDF

Source
http://Insights.ovid.com/crossref?an=00005792-201706300-0004
Publisher Site
http://dx.doi.org/10.1097/MD.0000000000007308DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5500059PMC
June 2017

Eficiency of different doses of rituximab in rheumatoid arthritis.

Reumatol Clin 2016 May-Jun;12(3):139-45. Epub 2015 Oct 14.

Unidad de Gestión Clínica de Reumatología, Instituto de investigación Biomédica de Málaga (IBIMA), Hospital Regional Universitario de Málaga, Universidad de Málaga, Málaga, España. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.reuma.2015.07.003DOI Listing
April 2017

A functional variant of TLR10 modifies the activity of NFkB and may help predict a worse prognosis in patients with rheumatoid arthritis.

Arthritis Res Ther 2016 10 4;18(1):221. Epub 2016 Oct 4.

Unidad de Genética, Hospital Universitario Marques de Valdecilla-Instituto de Investigación Valdecilla (IDIVAL), Avenida Valdecilla s/n, 39008, Santander, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13075-016-1113-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5050569PMC
October 2016

Characterization of Patients With Lupus Nephritis Included in a Large Cohort From the Spanish Society of Rheumatology Registry of Patients With Systemic Lupus Erythematosus (RELESSER).

Medicine (Baltimore) 2016 Mar;95(9):e2891

From the Rheumatology Department, Hospital 12 Octubre, Madrid (MG-I, ER-A); Rheumatology (JMP-R), University Hospital Complex, Instituto de Investigación Biomédica, Vigo, Spain; Rheumatology Department (FJL-L), Gregorio Marañón University Hospital, Madrid; Rheumatology Department (JC-A), Sierrallana Hospital, Torrelavega; Rheumatology Department (AO), Germans Trías i Pujol University Hospital, Badalona; Rheumatology Department (AF-N), Hospital Regional Universitario de Málaga, Málaga; Rheumatology Department (VM-T), Marques de Valdecilla Hospital, Santander; Rheumatology Department (PV-C), Hospital General de Alicante, Alicante; Rheumatology Department (MF), Hospital Universitario Juan Canalejo, Coruña; Rheumatology Department (FJN), Hospital Universitario de Bellvitge, Barcelona; Rheumatology Department (JR), Hospital Marina Baixa, Villajoyosa; Rheumatology Department (MI-B), Hospital Son Llatzer, Palma de Mallorca; Rheumatology Department (EU), Hospital de Donosti, San Sebastián; Rheumatology Department (ET), Hospital Universitario de La Princesa; Rheumatology Department (AZ), Hospital Universitario Ramón y Cajal, Madrid; Rheumatology Department (LH), Complejo Hospitalario de Navarra, Pamplona; Rheumatology Department (VT), Hospital Moisés Broggi; Rheumatology Department (IC), Hospital de la Santa Creu i Sant Pau, Barcelona; Rheumatology Department (JC), Hospital Parc Taulí. Sabadell; Rheumatology Department (RM-A), Hospital de Jerez, Jerez de la Frontera; Rheumatology Department (MAAZ), IMIBIC-Reina Sofia Hospital, Cordoba; Rheumatology Department (ER), University Hospital San Cecilio, Granada; Rheumatology Department (ED-Á), Leon Hospital, Leon; Rheumatology Department (TV-R), Hospital Lucus Augusti, Lugo; Rheumatology Department (PGDlP), Hospital Norte Sanchinarro, Madrid; Rheumatology Department (AM), Hospital Universitario Príncipe de Asturias, Alcalá de Henares; Rheumatology Department (JLA), Hospital Puerta de Hierro, Majadahonda, Madrid; Rhe

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0000000000002891DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4782862PMC
March 2016

FCGR polymorphisms in the treatment of rheumatoid arthritis with Fc-containing TNF inhibitors.

Pharmacogenomics 2015 ;16(4):333-45

Laboratorio de Investigacion 10 & Rheumatology Unit, Instituto de Investigacion Sanitaria - Hospital Clinico Universitario de Santiago, Travesia da Choupana s/n, 15706, Santiago de Compostela, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/pgs.14.175DOI Listing
January 2016

Insulin resistance and levels of adipokines in patients with untreated early rheumatoid arthritis.

Clin Rheumatol 2016 Jan 3;35(1):43-53. Epub 2015 Nov 3.

UGC de Reumatología, Instituto de Investigación Biomédica de Málaga (IBIMA), Hospital Regional Universitario de Málaga, Universidad de Málaga, Málaga, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10067-015-3106-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4710654PMC
January 2016

Examining the prevalence of non-criteria anti-phospholipid antibodies in patients with anti-phospholipid syndrome: a systematic review.

Rheumatology (Oxford) 2015 Nov 7;54(11):2042-50. Epub 2015 Jul 7.

Centre for Rheumatology Research, Division of Medicine, Department of Medicine, Rayne Institute, 5 University Street and

View Article

Download full-text PDF

Source
http://rheumatology.oxfordjournals.org/content/54/11/2042.fu
Web Search
http://www.rheumatology.oxfordjournals.org/lookup/doi/10.109
Publisher Site
http://dx.doi.org/10.1093/rheumatology/kev226DOI Listing
November 2015

Cardiovascular Events in Systemic Lupus Erythematosus: A Nationwide Study in Spain From the RELESSER Registry.

Medicine (Baltimore) 2015 Jul;94(29):e1183

On behalf of EAS-SER (Systemic Diseases Study Group of the Spanish Society of Rheumatology) From the UGC Reumatología (AFN), Instituto de Investigación Biomédica (IBIMA), Hospital Regional Universitario de Málaga, Universidad de Málaga, Málaga; Department of Rheumatology (ÍRF), Dr Negrín General University Hospital, Las Palmas de Gran Canaria, Gran Canaria; Department of Rheumatology (FLL), Gregorio Marañón University Hospital; Department of Rheumatology (MGI), Doce de Octubre University Hospital, Madrid; Department of Rheumatology (JCA), Sierrallana Hospital, Torrelavega; Department of Rheumatology (AOM), Germans Trías i Pujol University Hospital, Badalona; UGC Reumatología (COC), Instituto de Investigación Biomédica (IBIMA), Hospital Regional Universitario de Málaga, Universidad de Málaga, Málaga; Research Unit of Spanish Society of Rheumatology (MMM), Madrid; Department of Rheumatology (RB), Marqués de Valdecilla University Hospital, Santander; Department of Rheumatology (RMG), Hospital Complex of Ourense, Ourense; Department of Rheumatology (JIR), POVISA Hospital, Vigo; Department of Rheumatology (JBV), Alicante General University Hospital, Alicante; Department of Rheumatology (ETM), La Princesa University Hospital, Madrid; Department of Rheumatology (EUI), Donosti University Hospital, Guipuzcoa; Department of Rheumatology (LHR), Navarra Hospital, Pamplona; Department of Rheumatology (MFG), Juan Canalejo University Hospital, La Coruña; Department of Rheumatology (JN), Bellvitge University Hospital, Barcelona; Department of Rheumatology (ALB), Ramón y Cajal University Hospital, Madrid; Department of Rheumatology (GSS), Marina Baixa University Hospital, Villajoyosa, Alicante; Department of Rheumatology (JAS), Puerta del Hierro-Majadahonda Hospital, Madrid; and University Hospital Complex (JMPR), Instituto de Investigación Biomédica de Vigo (IBIV), Vigo, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0000000000001183DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4603000PMC
July 2015

Incidence of cancer in a cohort of Spanish patients with systemic lupus erythematosus.

Reumatol Clin 2013 Nov-Dec;9(6):359-64. Epub 2013 Oct 5.

Hospital Universitario "Virgen de la Victoria", Malaga, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.reuma.2012.10.015DOI Listing
April 2015

Comprehensive description of clinical characteristics of a large systemic lupus erythematosus cohort from the Spanish Rheumatology Society Lupus Registry (RELESSER) with emphasis on complete versus incomplete lupus differences.

Medicine (Baltimore) 2015 Jan;94(1):e267

From the Doctor Negrín University Hospital of Gran Canaria, Las Palmas GC, Las Plamas, Spain (ÍRF); Rheumatology Department Hospital Infanta Sofía, Madrid Spain (PR); Rheumatology Department Gregorio Marañón University Hospital, Madrid Spain (FJLL); Rheumatology Department Doce de Octubre University Hospital, Madrid Spain (MG); Rheumatology Department Sierrallana Hospital, Torrelavega Spain (JCA); Rheumatology Department Germans Trías i Pujol University Hospital, Badalona Spain (AOM); Research Unit Spanish Society of Rheumatology, Madrid Spain (ELS); Statistical Department Research Unit. Spanish Society of Rheumatology (SER); Madrid Spain (SPV); Rheumatology Department Dr Negrin General Hospital, Las Palmas de Gran Canaria, Spain (CE); Rheumatology Department La Princesa University Hospital, Madrid Spain (ET); Rheumatology Department Navarra Hospital Spain (LH); Rheumatology Department Donosti Hospital, Guipuzcoa Spain (EU); Rheumatology Department Príncipe de Asturias University Hospital, Madrid, Spain (ASA); Rheumatology Department H Marina Baixa, Alicante Spain (JR); Rheumatology Department Salamanca Clinic University Hospital Spain (CM); Rheumatology Department Carlos Haya University Hospital, Málaga, Spain (AFN); Rheumatology Department Hospital Complex of Ourense, Ourense Spain (MRG); Rheumatology Department Alicante General Hospital, Alicante, Spain (PV); Rheumatology Department Marqués de Valdecilla University Hospital, Santander Spain (RB); Rheumatology Department Juan Canalejo University Hospital, La Coruña Spain (MF); Rheumatology Department Guadalajara Hospital, Guadalajara Spain (LS); Rheumatology Department León Hospital, León Spain (EDÁ); Rheumatology Department Son Llatzer Hospital, Mallorca Spain (MIB); Rheumatology Department Ramon y Cajal, University Hospital, Madrid Spain (AZ); Rheumatology Department Bellvitge Hospital, Barcelona, Spain (JN); Rheumatology Department Marqués de Valdecilla University Hospital, Santander Spain (VMT);

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0000000000000267DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4602842PMC
January 2015

Efficacy and safety of rituximab in the treatment of non-renal systemic lupus erythematosus: a systematic review.

Semin Arthritis Rheum 2014 Oct 13;44(2):175-85. Epub 2014 Apr 13.

Rheumatology Department, Hospital Universitario Infanta Sofía, Paseo de Europa, 34, San Sebastián de los Reyes 28702, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.semarthrit.2014.04.002DOI Listing
October 2014

Association of FCGR2A with the response to infliximab treatment of patients with rheumatoid arthritis.

Pharmacogenet Genomics 2014 May;24(5):238-45

aResearch Laboratory 10 and Rheumatology Unit, Health Research Institute, University Clinic Hospital of Santiago bDepartment of Medicine, University of Santiago de Compostela, Santiago de Compostela cRheumatology Unit, University Hospital of Bellvitge dRheumatology Unit, University Hospital Clinic eRheumatology Unit, Hospital Santa Creu e San Pau, Barcelona fRheumatology Unit, University Hospital Virgen Macarena, Sevilla gUGC of Rheumatology, University Regional Hospital of Málaga, Biomedical Research Institute of Málaga, University of Málaga, Málaga hRheumatology Unit, University Hospital Virgen de las Nieves, Granada iRheumatology Unit, Hospital 12 of October, Madrid, Spain jDepartament of Biochemistry and Biotechnology, University of Thessaly, Larissa, Greece.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/FPC.0000000000000042DOI Listing
May 2014

Quality-of-care standards for early arthritis clinics.

Rheumatol Int 2013 Oct 9;33(10):2459-72. Epub 2013 Apr 9.

Hospital Universatario La Fe, Valencia, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00296-013-2741-0DOI Listing
October 2013

[Use of rituximab in the treatment of lupus patients. The LESIMAB database].

Reumatol Clin 2010 Sep 4;6 Suppl 2:28-33. Epub 2010 Aug 4.

Sección de Reumatología, Hospital Universitario Virgen de Valme, Sevilla, España.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.reuma.2010.06.002DOI Listing
September 2010

Long-term TNF-alpha blockade in patients with amyloid A amyloidosis complicating rheumatic diseases.

Am J Med 2010 May;123(5):454-61

Servicio de Reumatología y Departamento de Medicina de la Facultad de Medicina, Hospital Regional Universitario Carlos Haya, Málaga, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjmed.2009.11.010DOI Listing
May 2010

[Clinical and immunological features in 112 patients with antiphospholipid syndrome].

Med Clin (Barc) 2004 Oct;123(12):466-70

Unidad de Enfermedades Autoinmunes Sistémicas, Servicio de Medicina Interna, Hospital Regional Universitario Carlos Haya, Málaga, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1157/13067087DOI Listing
October 2004